Abstract:Objective To find out the factors which influence plasma N-terminal pro-B-type natriuretic peptide(NT-proBNP) levels and assess whether preoperative plasma NT-proBNP levels can predict postoperative outcomes of cardiac surgery. Methods A total of 120 patients including 83 males and 37 females undergoing various cardiac procedures between December 2008 and May 2009 were included in the study.Their age ranged from 25 to 84 years with an average age of 62.13 years.Through pathological diagnosis,35 patients had heart valve diseases,74 had coronary artery diseases,3 had congenital heart diseases and 8 had aortic aneurysm.NT-proBNP,creatinine,cardiac troponin T(cTnT) and creatine kinase-MB(CK-MB) levels were measured preoperatively and 24 hours after operation.Ventilation time,length of stay in ICU or in hospital,and mortality were closely monitored after operation.The following events were regarded as endpoints:(1) ICU stay time>4 d;(2) Ventilation time>48 h;(3) Death occurred during the first 30 days after operation.Receiver operating characteristic(ROC) curve was used to analyze the prediction function of NT-proBNP on endpoint events.Based on the cut-off value,the patients were divided into the NT-proBNP increasing group and non-increasing group.Univariate and logistic multi-factor analysis were adopted to analyze factors which had an influence on preoperative NT-proBNP level. Results NT-proBNP concentration increased significantly from 37.5-30 867.0 pg/ml(1 929.12±3 749.44 pg/ml) preoperatively to 177.7-35 000.0 pg/ml(2 950.32±4 006.14 pg/ml) 24 hours after operation(t=-2.599,P=0.012).ROC curve demonstrated that a cut-off value above 867 pg/ml preoperatively could predict endpoint events with a sensitivity of 77.8% and a specificity of 62.7%.Ventilation time and length of stay in hospital for the patients in the NT-proBNP increasing group were significantly longer than those of patients in the non-increasing group(26.44±32.75 h vs.14.49±9.23 h,t=2.507,P=0.015;23.70±24.02 d vs.16.21±8.11 d,t=2.117,P=0.039).Influencing factors on preoperative NT-proBNP level included preoperative atrial fibrillation,heart function classification,left ventricular end-diastolic dimension(LVEDD), ejection fraction(EF),pulmonary artery pressure,preoperative creatinine,cTnT and pathological diagnosis.EF(P=0.007) and preoperative atrial fibrillation(P=0.018) were independently associated with preoperative NT-proBNP level.Preoperative NT-proBNP was closely related to ventilation time(P=0.015),and length of stay in hospital(P=0.039). Conclusion Preoperative plasma NT-proBNP level presents a high individual variability in patients undergoing cardiac surgery.Ejection fraction and preoperative atrial fibrillation are independently associated with preoperative NT-proBNP level.Preoperative NT-proBNP is a valuable marker in predicting bad outcome in patients undergoing heart surgery.

Recent progress in study of serum N-terminal pro-brain natriuretic peptide in perioperative cardiac surgical patients

Perioperative Application of N-terminal Pro-Brain Natriuretic Peptide in Patients Undergoing Cardiac Surgery

Clinical Significance and Progress in Research of Perioperative Brain Natriuretic Peptide

Brain Natriuretic Peptide and Optimal Management of Heart Failure.

Plasma Concentration of Brain Natriuretic Peptide and Heart Dysfunction

Recombinant Human B-type Natriuretic Peptides in Cardiac Surgical Procedures

N-terminal pro-Brain natriuretic peptide as a useful biomarker for monitoring prognosis in patients with cardiac valve replacement.

Influence Factors and Prognosis Prediction Function of Preoperative N-terminal Pro-B-type Natriuretic Peptide in Patients Undergoing Cardiac Surgery

Issues that challenge our attention about B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in clinical use

Brain Natriuretic Peptide and Current Clinical Applications

Advances in Research of Brain Natriuretic Peptide in Cardiovascular Disease

The Use of B-type Natriuretic Peptide in the Management of Perioperative Heart Failure

Meaning of Perioperative Plasma Concentration of NT-ProBNP in the Risk Assessment of Rheumatic Valve Disease

Progress in the Application of Brain Natriuretic Peptide in Chronic Obstructive Pulmonary Disease

Study on the N-terminal pro-brain natriuretic peptide level in acute coronary syndrome

Corelation Between Plasma N-terminal ProBNP(NT-proBNP) and Cardiac Dysfunction

Clinical application and evaluation of N-terminal pro-Brain natriuretic peptide quantitative detection in heart failure laboratory diagnosis

Value of Serum N-terminal Pro-B-type Natriuretic Peptide for the Diagnosis and Prognosis Evaluation in Patients with Coronary Heart Disease

Predictive Value of N-terminal Pro-B-type Natriuretie Peptide on Prognosis of Critically Ill Patients in Surgical Intensive Care Unit and Its Possible Influential Factors

Plasma BNP Combined with NT-proBNP versus Routine Cardiac Function Parameters for Predicting Postoperative Prognosis in Patients with Heart Valve Replacement Surgery:a Comparative Study

The Application of N-terminal Pro-brain B-type Natriuretic Peptides in the Diagnosis of Elderly Patients with Chronic Heart Failure